Which of the following statements is false regarding calcium needs during pregnancy? 2024

Xem Which of the following statements is false regarding calcium needs during pregnancy? 2024

How much food from the Dairy Group is needed daily?

Your dairy needs depends on your age, sex, height, weight, and activity level. The amount can also depend on whether you are pregnant or breastfeeding.

About 90% of Americans do not get enough dairy. Most people would benefit from getting more fat-free or low-fat dairy. This can come from milk, yogurt, or cheese. It can also come from lactose-free milk and fortified soy milk or yogurt.

Find
the right amount of dairy for you by getting your MyPlate Plan. For general guidance based on age, see the table below.

What counts as a cup in the Dairy Group?

In general, the following counts as 1 cup from the Dairy Group:

• 1 cup of milk, yogurt, or soy milk
• 1 ½ ounces of natural cheese

The table below lists specific amounts that count as 1 cup from the Dairy Group.

FAQ001
Last updated: March 2022
Last reviewed: December 2021

Copyright 2022 by the American College of Obstetricians and Gynecologists. All rights reserved. Read copyright and permissions information.

This information is designed as an educational aid for the public. It offers current information and opinions related to women’s health. It is not intended as a
statement of the standard of care. It does not explain all of the proper treatments or methods of care. It is not a substitute for the advice of a physician. Read ACOG’s complete disclaimer.

Summary

Read the full fact sheet

• Calcium is vital for healthy teeth and bones. 
• It is also important for the health and functioning of nerves and muscle tissue.
• Good sources of calcium include dairy foods like milk, yoghurt and cheese, calcium fortified foods (such as soy products) and, to a lesser degree, some leafy green vegetables and nuts and seeds. 
• If you don’t have enough calcium in your diet, you may be at increased risk of developing osteoporosis.

This page has been produced in consultation with and approved by:

This page has been produced in consultation with and approved by:

Related information

• The abdominal muscles support the trunk, allow movement and hold organs in place by regulating internal abdominal pressure.

• Acromegaly is caused by an excess of growth hormone in adults, which causes the overgrowth of bones in the face,
  hands, feet and internal organs.

• Exercise can prevent age-related
  changes to muscles, bones and joints and can reverse these changes too.

• The size of a standard drink can vary according to the type of
  alcohol.

• A person with amyloidosis produces aggregates of insoluble protein that cannot be eliminated from
  the body.

From other websites

Content disclaimer

Content on this website is provided for information purposes only. Information about a therapy, service, product or treatment does not in any way endorse or support such therapy, service, product or treatment and is not intended to replace advice from your doctor or other registered health
professional. The information and materials contained on this website are not intended to constitute a comprehensive guide concerning all aspects of the therapy, product or treatment described on the website. All users are urged to always seek advice from a registered health care professional for diagnosis and answers to their medical questions and to ascertain whether the particular therapy, service, product or treatment described on the website is suitable in their circumstances. The State of
Victoria and the Department of Health shall not bear any liability for reliance by any user on the materials contained on this website.

1.

Kovacs CS. Maternal Mineral and Bone Metabolism During Pregnancy, Lactation, and Post-Weaning Recovery. Physiol Rev. 2016;96:449–547. [PubMed: 26887676]

2.

Wysolmerski JJ. Conversations between breast and bone: physiological bone loss during lactation
as evolutionary template for osteolysis in breast cancer and pathological bone loss after menopause. BoneKEy. 2007;4:209–225.

3.

Kovacs CS. Calcium and bone metabolism disorders during pregnancy and lactation. Endocrinol Metab Clin North Am. 2011;40:795–826.
[PubMed: 22108281]

4.

Kovacs CS. The role of vitamin D in pregnancy and lactation: insights from animal models and clinical studies. Annu Rev Nutr. 2012;32:97–123.
[PubMed: 22483092]

5.

Kovacs CS. Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones. Physiol Rev. 2014;94:1143–1218.
[PubMed: 25287862]

6.

Kovacs CS. Physiology of calcium, phosphorus, and bone metabolism during pregnancy, lactation, and postweaning. In: Kovacs CS, Deal CL, eds. Maternal-Fetal and Neonatal Endocrinology: Physiology, Pathophysiology, and Clinical Management. San Diego: Academic Press; 2019:61-73.

7.

Kovacs CS, Chakhtoura M, El-Hajj Fuleihan G. Disorders of mineral and bone metabolism during pregnancy and lactation. In: Kovacs CS, Deal CL, eds. Maternal-Fetal and Neonatal Endocrinology: Physiology, Pathophysiology, and Clinical Management. San Diego: Academic Press; 2019:329-370.

8.

Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev. 1997;18:832–872.
[PubMed: 9408745]

9.

Haddad JG Jr, Boisseau V, Avioli LV. Placental transfer of vitamin D3 and 25-hydroxycholecalciferol in the rat. J Lab Clin Med. 1971;77:908–915.
[PubMed: 4327020]

10.

Hillman LS, Slatopolsky E, Haddad JG. Perinatal vitamin D metabolism. IV. Maternal and cord serum 24,25-dihydroxyvitamin D concentrations. J Clin Endocrinol Metab. 1978;47:1073–1077. [PubMed: 318093]

11.

Ardawi MS, Nasrat HA. HS BAA. Calcium-regulating hormones and parathyroid hormone-related peptide in normal human pregnancy and postpartum: a longitudinal study. Eur J Endocrinol. 1997;137:402–409.
[PubMed: 9368509]

12.

Bikle DD, Gee E, Halloran B, Haddad JG. Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease. J Clin Invest. 1984;74:1966–1971.
[PMC free article: PMC425383] [PubMed: 6549014]

13.

Zhang JY, Lucey AJ, Horgan R, Kenny LC, Kiely M. Impact of pregnancy on vitamin D status: a
longitudinal study. Br J Nutr. 2014;112:1081–1087. [PubMed: 25159824]

14.

Hollis BW, Johnson D, Hulsey TC, Ebeling M, Wagner CL. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner Res.
2011;26:2341–2357. [PMC free article: PMC3183324] [PubMed: 21706518]

15.

Markestad T, Ulstein M, Aksnes L, Aarskog D.
Serum concentrations of vitamin D metabolites in vitamin D supplemented pregnant women. A longitudinal study. Acta Obstet Gynecol Scand. 1986;65:63–67. [PubMed: 3487197]

16.

Ritchie LD, Fung EB, Halloran BP, Turnlund JR, Van Loan MD, Cann CE, King JC. A longitudinal study of
calcium homeostasis during human pregnancy and lactation and after resumption of menses. Am J Clin Nutr. 1998;67:693–701. [PubMed: 9537616]

17.

Kirby BJ, Ma Y, Martin HM, Buckle Favaro KL, Karaplis AC, Kovacs CS. Upregulation of calcitriol during pregnancy and skeletal
recovery after lactation do not require parathyroid hormone. J Bone Miner Res. 2013;28:1987–2000. [PubMed: 23505097]

18.

Cooke-Hubley S, Kirby BJ, Suppiah S, Simmonds CS, Karaplis AC, Kovacs CS. Circulating FGF23 is regulated by PTH and calcitriol during fetal development
but low FGF23 does not significantly alter fetal phosphorus metabolism. IBMS BoneKEy. 2013;10:S95.

19.

Ma Y, Samaraweera M, Cooke-Hubley S, Kirby BJ, Karaplis AC, Lanske B, Kovacs CS. Neither absence nor excess of FGF23 disturbs murine fetal-placental phosphorus homeostasis or prenatal skeletal development and mineralization. Endocrinology. 2014;155:1596–1605.
[PMC free article: PMC3990847] [PubMed: 24601885]

20.

Fenton E, Britton HG. 25-hydroxycholecalciferol 1 alpha-hydroxylase activity in the kidney
of the fetal, neonatal and adult guinea pig. Biol Neonate. 1980;37:254–256. [PubMed: 7388079]

21.

Kubota M, Ohno J, Shiina Y, Suda T. Vitamin D metabolism in pregnant rabbits: differences between the maternal and fetal response to administration of large amounts of vitamin
D3. Endocrinology. 1982;110:1950–1956. [PubMed: 6280980]

22.

Turner M, Barre PE, Benjamin A, Goltzman D, Gascon-Barre M. Does the maternal kidney contribute to the increased circulating 1,25-dihydroxyvitamin D concentrations during pregnancy? Miner
Electrolyte Metab. 1988;14:246–252. [PubMed: 3211093]

23.

Gillies BR, Ryan BA, Tonkin BA, Poulton IJ, Ma Y, Kirby BJ, St-Arnaud R, Sims NA, Kovacs CS. Absence of Calcitriol Causes Increased Lactational Bone Loss and Lower Milk Calcium but Does Not Impair Post-lactation Bone Recovery in
Cyp27b1 Null Mice. J Bone Miner Res. 2018;33:16–26. [PubMed: 28686309]

24.

Ryan BA, Alhani K, Sellars KB, Kirby BJ, St-Arnaud R, Kaufmann M, Jones G, Kovacs CS. Mineral Homeostasis in Murine Fetuses Is Sensitive to Maternal Calcitriol but Not to Absence of Fetal Calcitriol.
J Bone Miner Res. 2019;34:669–680. [PubMed: 30508318]

25.

Bucht E, Telenius-Berg M, Lundell G, Sjoberg HE. Immunoextracted calcitonin in milk and plasma from totally thyroidectomized women. Evidence of monomeric calcitonin in plasma during pregnancy and lactation.
Acta Endocrinol (Copenh). 1986;113:529–535. [PubMed: 3788423]

26.

Woodrow JP, Sharpe CJ, Fudge NJ, Hoff AO, Gagel RF, Kovacs CS. Calcitonin plays a critical role in regulating skeletal mineral metabolism during lactation. Endocrinology. 2006;147:4010–4021.
[PubMed: 16675524]

27.

Woodrow JP. Calcitonin modulates skeletal mineral loss during lactation through interactions in mammary tissue and directly though osteoclasts in bone [PhD thesis] [PhD]. St. John’s, Newfoundland: Biomedical Sciences, Faculty of Medicine, Memorial University of Newfoundland; 2009.

28.

Hutchesson AC, Hughes SV, Bowden SJ, Ratcliffe WA. In vitro stability of endogenous parathyroid hormone-related protein in blood and plasma. Ann Clin Biochem. 1994;31(Pt 1):35–39. [PubMed: 7512317]

29.

Horwitz MJ, Tedesco MB, Sereika SM, Hollis BW,
Garcia-Ocana A, Stewart AF. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36). J Clin Endocrinol Metab. 2003;88:1603–1609. [PubMed: 12679445]

30.

Horwitz MJ, Tedesco MB, Sereika SM, Syed MA, Garcia-Ocana A, Bisello A, Hollis BW,
Rosen CJ, Wysolmerski JJ, Dann P, Gundberg C, Stewart AF. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D. J Bone Miner Res. 2005;20:1792–1803. [PubMed: 16160737]

31.

Cornish J, Callon KE, Nicholson GC,
Reid IR. Parathyroid hormone-related protein-(107-139) inhibits bone resorption in vivo. Endocrinology. 1997;138:1299–1304. [PubMed: 9048639]

32.

Kovacs CS, Lanske B, Hunzelman JL, Guo J, Karaplis AC, Kronenberg HM. Parathyroid hormone-related peptide (PTHrP) regulates
fetal-placental calcium transport through a receptor distinct from the PTH/PTHrP receptor. Proc Natl Acad Sci U S A. 1996;93:15233–15238. [PMC free article: PMC26386] [PubMed: 8986793]

33.

Ohata Y, Arahori H, Namba N, Kitaoka T, Hirai H, Wada K, Nakayama M, Michigami T, Imura A, Nabeshima Y, Yamazaki Y, Ozono K. Circulating levels of soluble alpha-Klotho are markedly elevated in human umbilical cord blood. J Clin Endocrinol Metab. 2011;96:E943–947.
[PubMed: 21411554]

34.

Clement-Lacroix P, Ormandy C, Lepescheux L, Ammann P, Damotte D, Goffin V, Bouchard B, Amling M, Gaillard-Kelly M, Binart N, Baron R, Kelly PA. Osteoblasts are a new target for prolactin: analysis of bone formation in prolactin receptor knockout mice. Endocrinology.
1999;140:96–105.
[PubMed: 9886812]

35.

Suntornsaratoon P, Wongdee K, Goswami S, Krishnamra N, Charoenphandhu N. Bone modeling in bromocriptine-treated pregnant and lactating rats: possible osteoregulatory role of prolactin in lactation. Am J Physiol Endocrinol Metab. 2010;299:E426–436.
[PubMed: 20551289]

36.

Thiede MA. The mRNA encoding a parathyroid hormone-like peptide is produced in mammary tissue in response to elevations in serum prolactin. Mol Endocrinol. 1989;3:1443–1447.
[PubMed: 2608067]

37.

Ratcliffe WA, Thompson GE, Care AD, Peaker M. Production of parathyroid hormone-related protein by the mammary gland of the goat. J Endocrinol. 1992;133:87–93.
[PubMed: 1517711]

38.

Stiegler C, Leb G, Kleinert R, Warnkross H, Ramschak-Schwarzer S, Lipp R, Clarici G, Krejs GJ, Dobnig H. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status. J Bone Miner Res. 1995;10:751–759.
[PubMed: 7639111]

39.

Dawood MY, Ylikorkala O, Trivedi D, Fuchs F. Oxytocin in maternal circulation and amniotic fluid during pregnancy. J Clin Endocrinol Metab. 1979;49:429–434.
[PubMed: 468976]

40.

Colucci S, Colaianni G, Mori G, Grano M, Zallone A. Human osteoclasts express oxytocin receptor. Biochem Biophys Res Commun. 2002;297:442–445.
[PubMed: 12270111]

41.

Tamma R, Colaianni G, Zhu LL, DiBenedetto A, Greco G, Montemurro G, Patano N, Strippoli M, Vergari R, Mancini L, Colucci S, Grano M, Faccio R, Liu X, Li J, Usmani S, Bachar M, Bab I, Nishimori K, Young LJ, Buettner C, Iqbal J, Sun L, Zaidi M, Zallone A. Oxytocin is an anabolic bone hormone.
Proc Natl Acad Sci U S A. 2009;106:7149–7154. [PMC free article: PMC2678458] [PubMed: 19369205]

42.

Liu X,
Shimono K, Zhu LL, Li J, Peng Y, Imam A, Iqbal J, Moonga S, Colaianni G, Su C, Lu Z, Iwamoto M, Pacifici M, Zallone A, Sun L, Zaidi M. Oxytocin deficiency impairs maternal skeletal remodeling. Biochem Biophys Res Commun. 2009;388:161–166. [PubMed: 19653998]

43.

Halloran BP,
DeLuca HF. Calcium transport in small intestine during pregnancy and lactation. Am J Physiol. 1980;239:E64–68. [PubMed: 6249126]

44.

Brommage R, Baxter DC, Gierke LW. Vitamin D-independent intestinal calcium and phosphorus absorption during reproduction. Am J
Physiol. 1990;259:G631–638. [PubMed: 2221074]

45.

Fudge NJ, Kovacs CS. Pregnancy up-regulates intestinal calcium absorption and skeletal mineralization independently of the vitamin D receptor. Endocrinology. 2010;151:886–895.
[PubMed: 20051486]

46.

Heaney RP, Skillman TG. Calcium metabolism in normal human pregnancy. J Clin Endocrinol Metab. 1971;33:661–670.
[PubMed: 5093770]

47.

Walker A, Fraile JJ, Hubbard JG. “Parathyroidectomy in pregnancy”-a single centre experience with review of evidence and proposal for treatment algorithim. Gland Surg. 2014;3:158–164.
[PMC free article: PMC4139131] [PubMed: 25207208]

48.

Morton A. Altered calcium homeostasis during pregnancy may affect biochemical
differentiation of hypercalcaemia. Intern Med J. 2004;34:655–656. [PubMed: 15546467]

49.

Pedersen EB, Johannesen P, Kristensen S, Rasmussen AB, Emmertsen K, Moller J, Lauritsen JG, Wohlert M. Calcium, parathyroid hormone and calcitonin in normal pregnancy and preeclampsia.
Gynecol Obstet Invest. 1984;18:156–164. [PubMed: 6489849]

50.

Frenkel Y, Barkai G, Mashiach S, Dolev E, Zimlichman R, Weiss M. Hypocalciuria of preeclampsia is independent of parathyroid hormone level. Obstet Gynecol. 1991;77:689–691.
[PubMed: 1849625]

51.

Seely EW, Wood RJ, Brown EM, Graves SW. Lower serum ionized calcium and abnormal calciotropic hormone levels in preeclampsia. J Clin Endocrinol Metab. 1992;74:1436–1440.
[PubMed: 1592891]

52.

Lalau JD, Jans I, el Esper N, Bouillon R, Fournier A. Calcium metabolism, plasma parathyroid hormone, and calcitriol in transient hypertension of pregnancy. Am J Hypertens. 1993;6:522–527.
[PubMed: 8343236]

53.

Purdie DW, Aaron JE, Selby PL. Bone histology and mineral homeostasis in human pregnancy. Br J Obstet Gynaecol. 1988;95:849–854.
[PubMed: 3191057]

54.

Kovacs CS, Fuleihan Gel H. Calcium and bone disorders during pregnancy and lactation. Endocrinol Metab Clin North Am. 2006;35:21–51. v.
[PubMed: 16310641]

55.

Moller UK, Vieth Streym S, Mosekilde L, Rejnmark L. Changes in bone mineral density and body composition during pregnancy and postpartum. A controlled cohort study. Osteoporos Int. 2012;23:1213–1223.
[PubMed: 21607805]

56.

To WW, Wong MW. Changes in bone mineral density of the os calcis as measured by quantitative ultrasound during pregnancy and 24 months after delivery. Aust N Z J Obstet Gynaecol. 2011;51:166–171.
[PubMed: 21466520]

57.

Sowers M. Pregnancy and lactation as risk factors for subsequent bone loss and osteoporosis. J Bone Miner Res. 1996;11:1052–1060.
[PubMed: 8854240]

58.

Kreiger N, Kelsey JL, Holford TR, O’Connor T. An epidemiologic study of hip fracture in postmenopausal women. Am J Epidemiol. 1982;116:141–148.
[PubMed: 7102649]

59.

Aloia JF, Vaswani AN, Yeh JK, Ross P, Ellis K, Cohn SH. Determinants of bone mass in postmenopausal women. Arch Intern Med. 1983;143:1700–1704.
[PubMed: 6615091]

60.

Aloia JF, Cohn SH, Vaswani A, Yeh JK, Yuen K, Ellis K. Risk factors for postmenopausal osteoporosis. Am J Med. 1985;78:95–100.
[PubMed: 3966495]

61.

Hreshchyshyn MM, Hopkins A, Zylstra S, Anbar M. Associations of parity, breast-feeding, and birth control pills with lumbar spine and femoral neck bone densities. Am J Obstet Gynecol. 1988;159:318–322.
[PubMed: 3407686]

62.

Dequeker J, Tobing L, Rutten V, Geusens P. Relative risk factors for osteoporotic fracture: a pilot study of the MEDOS questionnaire. Clin Rheumatol. 1991;10:49–53.
[PubMed: 2065507]

63.

Feldblum PJ, Zhang J, Rich LE, Fortney JA, Talmage RV. Lactation history and bone mineral density among perimenopausal women. Epidemiology. 1992;3:527–531.
[PubMed: 1420520]

64.

Cumming RG, Klineberg RJ. Breastfeeding and other reproductive factors and the risk of hip fractures in elderly women. Int J Epidemiol. 1993;22:684–691.
[PubMed: 8225744]

65.

Berning B, van Kuijk C, Schutte HE, Kuiper JW, Drogendijk AC, Fauser BC. Determinants of lumbar bone mineral density in normal weight, non-smoking women soon after menopause. A study using clinical data and quantitative computed tomography. Bone Miner. 1993;21:129–139.
[PubMed: 8358250]

66.

Cure CC, Ramirez PC, Lopez-Jaramillo P. Osteoporosis, pregnancy, and lactation. Lancet. 1998;352:1227–1228.
[PubMed: 9777872]

67.

Cure-Cure C, Cure-Ramirez P, Teran E, Lopez-Jaramillo P. Bone-mass peak in multiparity and reduced risk of bone-fractures in menopause. Int J Gynaecol Obstet. 2002;76:285–291.
[PubMed: 11880132]

68.

Bjornerem A, Ahmed LA, Jorgensen L, Stormer J, Joakimsen RM. Breastfeeding protects against hip fracture in postmenopausal women: the Tromso study. J Bone Miner Res. 2011;26:2843–2850.
[PubMed: 21898594]

69.

Chapman DJ. Longer cumulative breastfeeding duration associated with improved bone strength. Journal of human lactation : official journal of International Lactation Consultant Association 2012; 28:18-19.
[PubMed: 22267315]

70.

Canal-Macias ML, Roncero-Martin R, Moran JM, Lavado-Garcia JM, Costa-Fernandez Mdel C, Pedrera-Zamorano JD. Increased bone mineral density is associated with breastfeeding history in premenopausal Spanish women. Archives of medical science. AMS. 2013;9:703–708.
[PMC free article: PMC3776181] [PubMed: 24049532]

71.

Heidari B, Heidari P, Nourooddini HG, Hajian-Tilaki KO. Relationship between parity and
bone mass in postmenopausal women according to number of parities and age. J Reprod Med. 2013;58:389–394. [PubMed: 24050027]

72.

Schnatz PF, Marakovits KA, O’Sullivan DM. Assessment of postmenopausal women and significant risk factors for osteoporosis. Obstet
Gynecol Surv. 2010;65:591–596. [PubMed: 21144090]

73.

Schnatz PF, Barker KG, Marakovits KA, O’Sullivan DM. Effects of age at first pregnancy and breast-feeding on the development of postmenopausal osteoporosis. Menopause (New York, NY). 2010;17:1161–1166.
[PubMed: 20613669]

74.

Specker B, Binkley T. High parity is associated with increased bone size and strength. Osteoporos Int. 2005;16:1969–1974.
[PubMed: 16091837]

75.

Crandall CJ, Liu J, Cauley J, Newcomb PA, Manson JE, Vitolins MZ, Jacobson LT, Rykman KK, Stefanick ML. Associations of Parity, Breastfeeding, and Fractures in the Women’s Health Observational Study. Obstet Gynecol. 2017;130:171–180.
[PMC free article: PMC5484587] [PubMed: 28594759]

76.

Kovacs CS, Ralston SH. Presentation and management of osteoporosis presenting in
association with pregnancy or lactation. Osteoporos Int. 2015;26:2223–2241. [PubMed: 25939309]

77.

Dunne F, Walters B, Marshall T, Heath DA. Pregnancy associated osteoporosis. Clin Endocrinol (Oxf). 1993;39:487–490. [PubMed: 8287577]

78.

Phillips AJ, Ostlere SJ, Smith R. Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int. 2000;11:449–454.
[PubMed: 10912848]

79.

Laroche M, Talibart M, Cormier C, Roux C, Guggenbuhl P, Degboe Y. Pregnancy-related fractures: a retrospective study of a French cohort of 52 patients and review of the literature. Osteoporos Int. 2017;28:3135–3142.
[PubMed: 28879474]

80.

Herath M, Wong P, Trinh A, Allan CA, Wallace EM, Ebeling PR, Fuller PJ, Milat F. Minimal-trauma ankle fractures predominate during pregnancy: a 17-year retrospective study. Archives of osteoporosis. 2017;12:86.
[PubMed: 28965301]

81.

Dent CE, Friedman M. Pregnancy and idiopathic osteoporosis. Q J Med. 1965;34:341–357. [PubMed:
5838264]

82.

Nordin BE, Roper A. Post-pregnancy osteoporosis; a syndrome? Lancet. 1955;268:431–434. [PubMed: 13234409]

83.

Khovidhunkit W, Epstein S. Osteoporosis in pregnancy. Osteoporos Int. 1996;6:345–354.
[PubMed: 8931028]

84.

Smith R, Athanasou NA, Ostlere SJ, Vipond SE. Pregnancy-associated osteoporosis. Quarterly Journal of Medicine. 1995;88:865–878.
[PubMed: 8593546]

85.

Campos-Obando N, Oei L, Hoefsloot LH, Kiewiet RM, Klaver CC, Simon ME, Zillikens MC. Osteoporotic vertebral fractures during pregnancy: be aware of a potential underlying genetic cause. J Clin Endocrinol Metab. 2014;99:1107–1111.
[PubMed: 24423337]

86.

Cook FJ, Mumm S, Whyte MP, Wenkert D. Pregnancy-associated osteoporosis with a heterozygous deactivating LDL receptor-related protein 5 (LRP5) mutation and a homozygous methylenetetrahydrofolate reductase (MTHFR) polymorphism. J Bone Miner Res. 2014;29:922–928.
[PubMed: 24014470]

87.

Khastgir G, Studd JW, King H, Abdalla H, Jones J, Carter G, Alaghband-Zadeh J. Changes in bone density and biochemical markers of bone turnover in pregnancy-associated osteoporosis. Br J Obstet Gynaecol. 1996;103:716–718.
[PubMed: 8688403]

88.

Lakhanpal S, Ginsburg WW, Luthra HS, Hunder GG. Transient regional osteoporosis. A study of 56 cases and review of the literature. Ann Intern Med. 1987;106:444–450.
[PubMed: 3813239]

89.

Arayssi TK, Tawbi HA, Usta IM, Hourani MH. Calcitonin in the treatment of transient osteoporosis of the hip. Semin Arthritis Rheum. 2003;32:388–397.
[PubMed: 12833247]

90.

Curtiss PH Jr, Kincaid WE. Transitory demineralization of the hip in pregnancy. A report of three cases. The Journal of bone and joint surgery American volume. 1959;41-A:1327–1333.
[PubMed: 13849487]

91.

Baki ME, Uygun H, Ari B, Aydin H. Bilateral femoral neck insufficiency fractures in pregnancy. Eklem hastaliklari ve cerrahisi = Joint diseases & related surgery. 2014;25:60–62.
[PubMed: 24650388]

92.

Aynaci O, Kerimoglu S, Ozturk C, Saracoglu M. Bilateral non-traumatic acetabular and femoral neck fractures due to pregnancy-associated osteoporosis. Arch Orthop Trauma Surg. 2008;128:313–316.
[PubMed: 17828410]

93.

Bonacker J, Janousek M, Krober M. Pregnancy-associated osteoporosis with eight fractures in the vertebral column treated with kyphoplasty and bracing: a case report. Arch Orthop Trauma Surg. 2014;134:173–179.
[PubMed: 24357025]

94.

Pallavi P, Padma S, Vanitha Anna Selvi D. Transient osteoporosis of hip and lumbar spine in pregnancy. Journal of obstetrics and gynaecology of India. 2012;62:8–9.
[PMC free article: PMC3632689] [PubMed: 24293857]

95.

Iwamoto J, Sato Y, Uzawa M, Matsumoto H. Five-year follow-up of a woman with pregnancy and
lactation-associated osteoporosis and vertebral fractures. Therapeutics and clinical risk management. 2012;8:195–199. [PMC free article: PMC3333459] [PubMed: 22547939]

96.

Anai T, Tomiyasu T, Arima K, Miyakawa I. Pregnancy-associated osteoporosis with elevated levels of circulating parathyroid hormone-related protein: a report of two cases. The journal of obstetrics and gynaecology research. 1999;25:63–67.
[PubMed: 10067016]

97.

Tran HA, Petrovsky N. Pregnancy-associated osteoporosis with hypercalcaemia. Intern Med J. 2002;32:481–485.
[PubMed: 12380703]

98.

Segal E, Hochberg I, Weisman Y, Ish-Shalom S. Severe postpartum osteoporosis with increased PTHrP during lactation in a patient after total thyroidectomy and parathyroidectomy. Osteoporos Int. 2011;22:2907–2911.
[PubMed: 21243337]

99.

Liel Y, Atar D, Ohana N. Pregnancy-associated osteoporosis: preliminary densitometric evidence of extremely rapid recovery of bone mineral density. South Med J. 1998;91:33–35.
[PubMed: 9438399]

100.

Ijuin A, Yoshikata H, Asano R, Tsuburai T, Kikuchi R, Sakakibara H. Teriparatide and denosumab treatment for pregnancy and lactation-associated osteoporosis with multiple vertebral fractures: A case study. Taiwanese journal of obstetrics & gynecology. 2017;56:863–866.
[PubMed: 29241936]

101.

Hong N, Kim JE, Lee SJ, Kim SH, Rhee Y. Changes in bone mineral density and bone turnover markers during treatment with teriparatide in pregnancy- and lactation-associated osteoporosis. Clin Endocrinol (Oxf). 2018;88:652–658.
[PubMed: 29389010]

102.

Grizzo FM, da Silva Martins J, Pinheiro MM, Jorgetti V, Carvalho MD, Pelloso SM. Pregnancy and Lactation-Associated Osteoporosis: Bone Histomorphometric Analysis and Response to Treatment with Zoledronic Acid. Calcif Tissue Int. 2015;97:421–425. [PubMed: 26108650]

103.

Chan B, Zacharin M. Maternal and infant outcome after pamidronate treatment of polyostotic fibrous dysplasia and osteogenesis imperfecta before conception: a report of four cases. J Clin Endocrinol Metab. 2006;91:2017–2020.
[PubMed: 16551739]

104.

Tanriover MD, Oz SG, Sozen T. Ten-year follow-up in pregnancy and lactation-associated osteoporosis: sequential therapy with strontium ranelate and ibandronate. Spine J. 2015;15:1164–1165.
[PubMed: 25925624]

105.

Rodriguez AJ, Fink HA, Mirigian L, Guanabens N, Eastell R, Akesson K, Bauer DC, Ebeling PR. Pain, Quality of Life, and Safety Outcomes of Kyphoplasty for Vertebral Compression Fractures: Report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner
Res. 2017;32:1935–1944. [PubMed: 28513888]

106.

Kort KC, Schiller HJ, Numann PJ. Hyperparathyroidism and pregnancy. Am J Surg. 1999;177:66–68.
[PubMed: 10037311]

107.

Kelly TR. Primary hyperparathyroidism during pregnancy. Surgery. 1991;110:1028–1033. [PubMed:
1745971]

108.

Shangold MM, Dor N, Welt SI, Fleischman AR, Crenshaw MC Jr. Hyperparathyroidism and pregnancy: a review. Obstet Gynecol Surv. 1982;37:217–228. [PubMed: 7041021]

109.

Wagner G, Transhol L, Melchior JC. Hyperparathyroidism and
pregnancy. Acta Endocrinol (Copenh). 1964;47:549–564. [PubMed: 14250391]

110.

Ludwig GD. Hyperparathyroidism in relation to pregnancy. N Engl J Med. 1962;267:637–642.
[PubMed: 14467191]

111.

Delmonico FL, Neer RM, Cosimi AB, Barnes AB, Russell PS. Hyperparathyroidism during pregnancy. Am J Surg. 1976;131:328–337.
[PubMed: 769583]

112.

Bruce J, Strong JA. Maternal hyperparathyroidism and parathyroid deficiency in the child, with account of effect of parathyroidectomy on renal function, and of attempt to transplant part of tumor. Q J Med. 1955;24:307–319.
[PubMed: 13290019]

113.

Kristoffersson A, Dahlgren S, Lithner F, Jarhult J. Primary hyperparathyroidism in pregnancy. Surgery. 1985;97:326–330.
[PubMed: 3975852]

114.

Carella MJ, Gossain VV. Hyperparathyroidism and pregnancy: case report and review. J Gen Intern Med. 1992;7:448–453.
[PubMed: 1506954]

115.

Schnatz PF, Curry SL. Primary hyperparathyroidism in pregnancy: evidence-based management. Obstet Gynecol Surv. 2002;57:365–376.
[PubMed: 12140371]

116.

Abood A, Vestergaard P. Pregnancy outcomes in women with primary hyperparathyroidism. Eur J Endocrinol. 2014;171:69–76.
[PubMed: 24743398]

117.

Hirsch D, Kopel V, Nadler V, Levy S, Toledano Y, Tsvetov G. Pregnancy outcomes in women with primary hyperparathyroidism. J Clin Endocrinol Metab. 2015;100:2115–2122.
[PubMed: 25751112]

118.

Matthias GS, Helliwell TR, Williams A. Postpartum hyperparathyroid crisis. Case report. Br J Obstet Gynaecol. 1987;94:807–810.
[PubMed: 3663537]

119.

Clark D, Seeds JW, Cefalo RC. Hyperparathyroid crisis and pregnancy. Am J Obstet Gynecol. 1981;140:840–842.
[PubMed: 7258268]

120.

Salem R, Taylor S. Hyperparathyroidism in pregnancy. Br J Surg. 1979;66:648–650. [PubMed:
497655]

121.

Nilsson IL, Adner N, Reihner E, Palme-Kilander C, Edstrom G, Degerblad M. Primary hyperparathyroidism in pregnancy: a diagnostic and therapeutic challenge. J Womens Health (Larchmt). 2010;19:1117–1121. [PubMed: 20469964]

122.

Stathopoulos
IP, Liakou CG, Katsalira A, Trovas G, Lyritis GG, Papaioannou NA, Tournis S. The use of bisphosphonates in women prior to or during pregnancy and lactation. Hormones (Athens, Greece). 2011;10:280–291. [PubMed: 22281884]

123.

Boyce RW, Varela A, Chouinard L, Bussiere JL,
Chellman GJ, Ominsky MS, Pyrah IT. Infant cynomolgus monkeys exposed to denosumab in utero exhibit an osteoclast-poor osteopetrotic-like skeletal phenotype at birth and in the early postnatal period. Bone. 2014;64:314–325. [PubMed: 24727159]

124.

Okamatsu N, Sakai N,
Karakawa A, Kouyama N, Sato Y, Inagaki K, Kiuchi Y, Oguchi K, Negishi-Koga T, Takami M. Biological effects of anti-RANKL antibody administration in pregnant mice and their newborns. Biochem Biophys Res Commun. 2017;491:614–621. [PubMed: 28760341]

125.

Rajala B, Abbasi RA,
Hutchinson HT, Taylor T. Acute pancreatitis and primary hyperparathyroidism in pregnancy: treatment of hypercalcemia with magnesium sulfate. Obstet Gynecol. 1987;70:460–462. [PubMed: 3627603]

126.

Dahan M, Chang RJ. Pancreatitis secondary to hyperparathyroidism during
pregnancy. Obstet Gynecol. 2001;98:923–925. [PubMed: 11704205]

127.

Horjus C, Groot I, Telting D, van Setten P, van Sorge A, Kovacs CS, Hermus A, de Boer H. Cinacalcet for hyperparathyroidism in pregnancy and puerperium. J Pediatr Endocrinol Metab. 2009;22:741–749.
[PubMed: 19845125]

128.

Gonzalo Garcia I, Robles Fradejas M, Martin Macias MLA, Biain Ciganda A, Bustinza Beaskoetxea Z, Ruiz Perez E, Fernandez Matia G, Martinez Guisasola J. Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report. J Obstet Gynaecol. 2018;38:132–134.
[PubMed: 28760052]

129.

Vera L, Oddo S, Di Iorgi N, Bentivoglio G, Giusti M. Primary hyperparathyroidism in pregnancy treated with cinacalcet: a case report and review of the literature. Journal of medical case reports. 2016;10:361.
[PMC free article: PMC5175373] [PubMed: 27998296]

130.

Nadarasa K, Bailey M, Chahal H, Raja O, Bhat R, Gayle C, Grossman AB, Druce MR. The use of
cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma. Endocrinol Diabetes Metab Case Rep. 2014;2014:140056. [PMC free article: PMC4174590] [PubMed: 25298882]

131.

Kovacs CS, Ho-Pao CL, Hunzelman JL, Lanske B, Fox J, Seidman JG, Seidman CE, Kronenberg HM. Regulation of murine fetal-placental calcium metabolism by the calcium-sensing receptor. J Clin Invest. 1998;101:2812–2820.
[PMC free article: PMC508872] [PubMed: 9637715]

132.

Zeng H, Li Z, Zhang X, Wang N, Tian Y, Wang J. Anesthetic management of primary
hyperparathyroidism during pregnancy: A case report. Medicine (Baltimore). 2017;96:e9390. [PMC free article: PMC5758246] [PubMed:
29390544]

133.

Brown EM, Pollak M, Seidman CE, Seidman JG, Chou YH, Riccardi D, Hebert SC. Calcium-ion-sensing cell-surface receptors. N Engl J Med. 1995;333:234–240. [PubMed: 7791841]

134.

Jones AR, Hare MJ, Brown J, Yang J, Meyer C, Milat
F, Allan CA. Familial Hypocalciuric Hypercalcemia in Pregnancy: Diagnostic Pitfalls. JBMR Plus. 2020;4:e10362. [PMC free article: PMC7285754] [PubMed: 32537548]

135.

Powell BR, Buist NR. Late presenting, prolonged hypocalcemia in an infant of a woman with hypocalciuric hypercalcemia. Clin Pediatr (Phila). 1990;29:241–243.
[PubMed: 2331838]

136.

Thomas BR, Bennett JD. Symptomatic hypocalcemia and hypoparathyroidism in two infants of mothers with hyperparathyroidism and familial benign hypercalcemia. J Perinatol. 1995;15:23–26.
[PubMed: 7650548]

137.

Kovacs CS. Hypoparathyroidism during pregnancy, lactation, and fetal/neonatal development. In: Brandi ML, Brown EM, eds. Hypoparathyroidism. Milan: Springer; 2015:249-269.

138.

Khan AA, Clarke B, Rejnmark L, Brandi ML. MANAGEMENT OF ENDOCRINE DISEASE:
Hypoparathyroidism in pregnancy: review and evidence-based recommendations for management. Eur J Endocrinol. 2019;180:R37–r44. [PubMed: 30444723]

139.

Sweeney LL, Malabanan AO, Rosen H. Decreased calcitriol requirement during pregnancy and lactation with a window of
increased requirement immediately post partum. Endocr Pract. 2010;16:459–462. [PubMed: 20061285]

140.

Hatswell BL, Allan CA, Teng J, Wong P, Ebeling PR, Wallace EM, Fuller PJ, Milat F. Management of hypoparathyroidism in pregnancy and lactation – A report of 10 cases.
Bone Rep. 2015;3:15–19. [PMC free article: PMC5365205] [PubMed: 28377963]

141.

Hartogsohn EAR, Khan AA,
Kjaersulf LU, Sikjaer T, Hussain S, Rejnmark L. Changes in treatment needs of hypoparathyroidism during pregnancy and lactation: A case series. Clin Endocrinol (Oxf). 2020;93:261–268. [PubMed: 32350890]

142.

Wang JJ, Wang O, Wang YB, Yang J, Song A, Jiang Y, Li M, Xia WB,
Xing XP. Changes in serum calcium and treatment of hypoparathyroidism during pregnancy and lactation: A single-center case series. J Clin Endocrinol Metab. 2021 [PubMed: 34279662]

143.

Breslau NA, Zerwekh JE. Relationship of estrogen and pregnancy to calcium homeostasis in
pseudohypoparathyroidism. J Clin Endocrinol Metab. 1986;62:45–51. [PubMed: 3753557]

144.

O’Donnell D, Costa J, Meyers AM. Management of pseudohypoparathyroidism in pregnancy. Case report. Br J Obstet Gynaecol. 1985;92:639–641.
[PubMed: 4005206]

145.

Saito H, Saito M, Saito K, Terauchi A, Kobayashi T, Tominaga T, Hosoi E, Senoo M, Saito T. Subclinical pseudohypoparathyroidism type II: evidence for failure of physiologic adjustment in calcium metabolism during pregnancy. Am J Med Sci. 1989;297:247–250.
[PubMed: 2539718]

146.

Seki K, Osada H, Yasuda T, Sekiya S. Pseudohypoparathyroidism type 1b in pregnancy. Gynecol Obstet Invest. 1999;47:278–280.
[PubMed: 10352393]

147.

Ochiai D, Uchino H, Ikeda T, Yakubo K, Fukuiya T. Pseudohypoparathyroidism type 1a in pregnancy. J Obstet Gynaecol. 2013;33:900.
[PubMed: 24219739]

148.

Guedes Ramallo P, Boix Carreno E. Management of pseudohypoparathyroidism in pregnancy: a case report. J Obstet Gynaecol. 2017;37:519–520.
[PubMed: 27981863]

149.

Glass EJ, Barr DG. Transient neonatal hyperparathyroidism secondary to maternal pseudohypoparathyroidism. Arch Dis Child. 1981;56:565–568.
[PMC free article: PMC1627360] [PubMed: 7271292]

150.

Vidailhet M, Monin P, Andre M, Suty Y, Marchal C, Vert P. Arch Fr Pediatr.
1980;37:305–312. [Neonatal hyperparathyroidism secondary to maternal hypoparathyroidism] [PubMed: 7469705]

151.

Khosla S, van Heerden JA, Gharib H, Jackson IT, Danks J, Hayman JA, Martin TJ. Parathyroid hormone-related protein and hypercalcemia secondary to massive mammary hyperplasia.
N Engl J Med. 1990;322:1157. [PubMed: 2320085]

152.

Jackson IT, Saleh J, van Heerden JA. Gigantic mammary hyperplasia in pregnancy associated with pseudohyperparathyroidism. Plastic and reconstructive surgery. 1989;84:806–810.
[PubMed: 2813591]

153.

Sato K. Hypercalcemia during pregnancy, puerperium, and lactation: review and a case report of hypercalcemic crisis after delivery due to excessive production of PTH-related protein (PTHrP) without malignancy (humoral hypercalcemia of pregnancy). Endocr J. 2008;55:959–966.
[PubMed: 18614854]

154.

Marx SJ, Zusman RM, Umiker WO. Benign breast dysplasia causing hypercalcemia. J Clin Endocrinol Metab. 1977;45:1049–1052.
[PubMed: 925130]

155.

Eller-Vainicher C, Ossola MW, Beck-Peccoz P, Chiodini I. PTHrP-associated hypercalcemia of pregnancy resolved after delivery: a case report. Eur J Endocrinol. 2012;166:753–756.
[PubMed: 22247017]

156.

Kovacs CS, Ward LE. Disorders of calcium, phosphorus, and bone metabolism during fetal and neonatal development. In: Kovacs CS, Deal CL, eds. Maternal-Fetal and Neonatal Endocrinology: Physiology, Pathophysiology, and Clinical Management. San Diego: Academic Press; 2019:755-782.

157.

Rosen CJ, Adams JS, Bikle DD, Black DM, Demay MB, Manson JE, Murad MH, Kovacs CS. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012;33:456–492. [PMC free article: PMC3365859] [PubMed: 22596255]

158.

Brooke OG, Brown IR, Bone CD, Carter ND, Cleeve HJ, Maxwell JD, Robinson VP, Winder SM. Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. Br Med J. 1980;280:751–754.
[PMC free article: PMC1600591] [PubMed: 6989438]

159.

Roth DE, Al Mahmud A, Raqib R, Akhtar E, Perumal N, Pezzack B, Baqui AH. Randomized
placebo-controlled trial of high-dose prenatal third-trimester vitamin D3 supplementation in Bangladesh: the AViDD trial. Nutrition journal. 2013;12:47. [PMC free article: PMC3641012] [PubMed: 23587190]

160.

Wagner CL, McNeil R, Hamilton SA, Winkler J, Rodriguez Cook C, Warner G, Bivens B, Davis DJ, Smith PG, Murphy M, Shary JR, Hollis BW. A randomized trial of vitamin D supplementation in 2 community health center networks in South Carolina. Am J Obstet Gynecol 2013; 208:137 e131-113.
[PMC free article: PMC4365423] [PubMed: 23131462]

161.

Dawodu A, Saadi HF, Bekdache G, Javed Y, Altaye M, Hollis BW. Randomized controlled trial
(RCT) of vitamin D supplementation in pregnancy in a population with endemic vitamin D deficiency. J Clin Endocrinol Metab. 2013;98:2337–2346. [PubMed: 23559082]

162.

Grant CC, Stewart AW, Scragg R, Milne T, Rowden J, Ekeroma A, Wall C, Mitchell EA, Crengle S, Trenholme A,
Crane J, Camargo CA Jr. Vitamin D during pregnancy and infancy and infant serum 25-hydroxyvitamin D concentration. Pediatrics. 2014;133:e143–153. [PubMed: 24344104]

163.

Vaziri F, Dabbaghmanesh MH, Samsami A, Nasiri S, Shirazi PT. Vitamin D supplementation during pregnancy
on infant anthropometric measurements and bone mass of mother-infant pairs: A randomized placebo clinical trial. Early Hum Dev. 2016;103:61–68. [PubMed: 27513714]

164.

Cooper C, Harvey NC, Bishop NJ, Kennedy S, Papageorghiou AT, Schoenmakers I, Fraser R, Gandhi SV, Carr A,
D’Angelo S, Crozier SR, Moon RJ, Arden NK, Dennison EM, Godfrey KM, Inskip HM, Prentice A, Mughal MZ, Eastell R, Reid DM, Javaid MK, Group MS. Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial. The Lancet Diabetes & Endocrinology. 2016;4:393–402.
[PMC free article: PMC4843969] [PubMed: 26944421]

165.

Roth DE, Morris SK, Zlotkin S, Gernand AD, Ahmed T, Shanta SS, Papp E, Korsiak J, Shi J,
Islam MM, Jahan I, Keya FK, Willan AR, Weksberg R, Mohsin M, Rahman QS, Shah PS, Murphy KE, Stimec J, Pell LG, Qamar H, Al Mahmud A, Vitamin D. Supplementation in Pregnancy and Lactation and Infant Growth. N Engl J Med. 2018;379:535–546. [PMC free article: PMC6004541] [PubMed: 30089075]

166.

Kovacs CS, Ward LE. Physiology of calcium, phosphorus, and bone metabolism during fetal and neonatal development. In: Kovacs CS, Deal CL, eds. Maternal-Fetal and Neonatal Endocrinology: Physiology, Pathophysiology, and Clinical Management. San Diego: Academic Press; 2019:573-586.

167.

Kovacs CS. Analysis of the MAVIDOS trial. The Lancet Diabetes & Endocrinology. 2017;5:328. [PubMed: 28434489]

168.

Khaing W, Vallibhakara SA, Tantrakul V, Vallibhakara O, Rattanasiri S, McEvoy M, Attia J, Thakkinstian A. Calcium and Vitamin D
Supplementation for Prevention of Preeclampsia: A Systematic Review and Network Meta-Analysis. Nutrients. 2017:9. [PMC free article: PMC5691757] [PubMed:
29057843]

169.

De-Regil LM, Palacios C, Lombardo LK, Pena-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2016;1:CD008873. [PubMed: 26765344]

170.

Hypponen E, Cavadino A, Williams D, Fraser A,
Vereczkey A, Fraser WD, Banhidy F, Lawlor D, Czeizel AE. Vitamin D and pre-eclampsia: original data, systematic review and meta-analysis. Annals of nutrition & metabolism. 2013;63:331–340. [PubMed: 24603503]

171.

Thorne-Lyman A, Fawzi WW. Vitamin D during pregnancy and
maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatric and perinatal epidemiology. 2012;26 Suppl 1:75–90. [PMC free article: PMC3843348] [PubMed: 22742603]

172.

Roth DE, Leung M, Mesfin E, Qamar H, Watterworth J, Papp E. Vitamin D supplementation during pregnancy: state of the evidence from a systematic review of randomised trials. BMJ. 2017;359:j5237.
[PMC free article: PMC5706533] [PubMed: 29187358]

173.

Harvey NC, Holroyd C, Ntani G, Javaid K, Cooper P, Moon R, Cole Z, Tinati T, Godfrey K,
Dennison E, Bishop NJ, Baird J, Cooper C. Vitamin D supplementation in pregnancy: a systematic review. Health Technol Assess. 2014;18:1–190. [PMC free article: PMC4124722] [PubMed: 25025896]

174.

Palacios C, Kostiuk LK, Pena-Rosas JP. Vitamin D supplementation for women during pregnancy. Cochrane Database Syst Rev. 2019;7:Cd008873.
[PMC free article: PMC6659840] [PubMed: 31348529]

175.

Edouard T, Alos N, Chabot G, Roughley P, Glorieux FH, Rauch F. Short- and long-term
outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol. J Clin Endocrinol Metab. 2011;96:82–89. [PubMed: 20926527]

176.

Marx SJ, Swart EG Jr, Hamstra AJ, DeLuca HF. Normal intrauterine development of the fetus of a woman receiving
extraordinarily high doses of 1,25-dihydroxyvitamin D3. J Clin Endocrinol Metab. 1980;51:1138–1142. [PubMed: 6893458]

177.

Malloy PJ, Tiosano D, Feldman D. Hereditary 1,25-Dihydroxyvitamin-D-Resistant Rickets. In: Feldman D, Pike JW, Adams JS, eds. Vitamin D, Third Edition.
San Diego, CA: Academic Press; 2011:1197-1232.

178.

Carpenter TO. CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations. J Steroid Biochem Mol Biol. 2017;173:337–340. [PubMed: 28093352]

179.

Shah AD, Hsiao EC, O’Donnell B,
Salmeen K, Nussbaum R, Krebs M, Baumgartner-Parzer S, Kaufmann M, Jones G, Bikle DD, Wang Y, Mathew AS, Shoback D, Block-Kurbisch I. Maternal Hypercalcemia Due to Failure of 1,25-Dihydroxyvitamin-D3 Catabolism in a Patient With CYP24A1 Mutations. J Clin Endocrinol Metab. 2015;100:2832–2836. [PMC free
article: PMC4524985] [PubMed: 26097993]

180.

Dinour D, Davidovits M, Aviner S, Ganon L, Michael L, Modan-Moses D, Vered I, Bibi H, Frishberg Y, Holtzman EJ. Maternal and infantile hypercalcemia caused by vitamin-D-hydroxylase mutations and vitamin D intake. Pediatr Nephrol.
2015;30:145–152. [PubMed: 25194629]

181.

Woods GN, Saitman A, Gao H, Clarke NJ, Fitzgerald RL, Chi NW. A Young Woman With Recurrent Gestational Hypercalcemia and Acute Pancreatitis Caused by CYP24A1 Deficiency. J Bone Miner Res. 2016;31:1841–1844.
[PMC free article: PMC5071127] [PubMed: 27105398]

182.

Kwong WT, Fehmi SM. Hypercalcemic Pancreatitis Triggered by Pregnancy With a CYP24A1
Mutation. Pancreas. 2016;45:e31–32. [PubMed: 27295538]

183.

Prentice A. Micronutrients and the bone mineral content of the mother, fetus and newborn. J Nutr. 2003;133:1693S–1699S.
[PubMed: 12730486]

184.

Prentice A. Pregnancy and lactation. In: Glorieux FH, Petifor JM, Jüppner H, eds. Pediatric bone: biology & diseases. New York: Academic Press; 2003:249-269.

185.

Janakiraman V, Ettinger A, Mercado-Garcia A, Hu H, Hernandez-Avila M. Calcium supplements and bone
resorption in pregnancy: a randomized crossover trial. Am J Prev Med. 2003;24:260–264. [PubMed: 12657345]

186.

Koo WW, Walters JC, Esterlitz J, Levine RJ, Bush AJ, Sibai B. Maternal calcium supplementation and fetal bone mineralization. Obstet Gynecol.
1999;94:577–582. [PubMed: 10511362]

187.

Prentice A. Calcium in pregnancy and lactation. Annu Rev Nutr. 2000;20:249–272.
[PubMed: 10940334]

188.

Hofmeyr GJ, Atallah AN, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev. 2006;3:CD001059.
[PubMed: 16855957]

189.

Kumar A, Devi SG, Batra S, Singh C, Shukla DK. Calcium supplementation for the prevention of pre-eclampsia. Int J Gynaecol Obstet. 2009;104:32–36.
[PubMed: 18851852]

190.

Hiller JE, Crowther CA, Moore VA, Willson K, Robinson JS. Calcium supplementation in pregnancy and its impact on blood pressure in children and women: follow up of a randomised controlled trial. Aust N Z J Obstet Gynaecol. 2007;47:115–121.
[PubMed: 17355300]

191.

Villar J, Abdel-Aleem H, Merialdi M, Mathai M, Ali MM, Zavaleta N, Purwar M, Hofmeyr J, Nguyen TN, Campodonico L, Landoulsi S, Carroli G, Lindheimer M. World Health Organization randomized trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet
Gynecol. 2006;194:639–649. [PubMed: 16522392]

192.

Ross AC, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Manson JE, Mayne ST, Rosen CJ, Shapses SA. Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC:
Institute of Medicine, 2011.

193.

Ohata Y, Yamazaki M, Kawai M, Tsugawa N, Tachikawa K, Koinuma T, Miyagawa K, Kimoto A, Nakayama M, Namba N, Yamamoto H, Okano T, Ozono K, Michigami T. Elevated fibroblast growth factor 23 exerts its effects on placenta and regulates vitamin D metabolism in pregnancy of Hyp mice. J Bone Miner Res. 2014;29:1627–1638.
[PubMed: 24470103]

194.

Jonas AJ, Dominguez B. Low breast milk phosphorus concentration in familial hypophosphatemia. J Pediatr Gastroenterol Nutr. 1989;8:541–543.
[PubMed: 2723946]

195.

Reade TM, Scriver CR. Hypophosphatemic rickets and breast milk. N Engl J Med. 1979;300:1397. [PubMed:
440383]

196.

Greer FR, Lane J, Ho M. Elevated serum parathyroid hormone, calcitonin, and 1,25-dihydroxyvitamin D in lactating women nursing twins. Am J Clin Nutr. 1984;40:562–568. [PubMed: 6548076]

197.

Dobnig H, Kainer F, Stepan V, Winter R,
Lipp R, Schaffer M, Kahr A, Nocnik S, Patterer G, Leb G. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab. 1995;80:3699–3707. [PubMed: 8530622]

198.

Yamamoto M, Duong LT,
Fisher JE, Thiede MA, Caulfield MP, Rosenblatt M. Suckling-mediated increases in urinary phosphate and 3′,5′-cyclic adenosine monophosphate excretion in lactating rats: possible systemic effects of parathyroid hormone-related protein. Endocrinology. 1991;129:2614–2622. [PubMed: 1657580]

199.

VanHouten JN, Dann P, Stewart AF, Watson CJ, Pollak M, Karaplis AC, Wysolmerski JJ. Mammary-specific deletion of parathyroid hormone-related protein preserves bone mass during lactation. J Clin Invest. 2003;112:1429–1436. [PMC free article: PMC228471] [PubMed: 14597768]

200.

Kovacs CS, Chik CL. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels. J Clin Endocrinol Metab. 1995;80:3036–3042.
[PubMed: 7559893]

201.

Sowers MF, Hollis BW, Shapiro B, Randolph J, Janney CA, Zhang D, Schork A, Crutchfield M, Stanczyk F, Russell-Aulet M. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA. 1996;276:549–554.
[PubMed: 8709404]

202.

Kelly PA, Bachelot A, Kedzia C, Hennighausen L, Ormandy CJ, Kopchick JJ, Binart N. The role of prolactin and growth hormone in mammary gland development. Mol Cell Endocrinol. 2002;197:127–131.
[PubMed: 12431805]

203.

Dawood MY, Khan-Dawood FS, Wahi RS, Fuchs F. Oxytocin release and plasma anterior pituitary and gonadal hormones in women during lactation. J Clin Endocrinol Metab. 1981;52:678–683.
[PubMed: 6782115]

204.

Nishimori K, Young LJ, Guo Q, Wang Z, Insel TR, Matzuk MM. Oxytocin is required for nursing but is not essential for parturition or reproductive behavior. Proc Natl Acad Sci U S A. 1996;93:11699–11704.
[PMC free article: PMC38121] [PubMed: 8876199]

205.

VanHouten JN, Wysolmerski JJ. Low estrogen and high parathyroid hormone-related peptide levels
contribute to accelerated bone resorption and bone loss in lactating mice. Endocrinology. 2003;144:5521–5529. [PubMed: 14500568]

206.

Hernandez LL, Gregerson KA, Horseman ND. Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related
signals. Am J Physiol Endocrinol Metab. 2012;302:E1009–1015. [PMC free article: PMC3774078] [PubMed: 22318950]

207.

Horseman ND, Hernandez LL. New concepts of breast cell communication to bone. Trends Endocrinol Metab. 2014;25:34–41. [PubMed: 24055165]

208.

Kolthoff N, Eiken P, Kristensen B, Nielsen SP. Bone mineral changes during pregnancy and lactation: a longitudinal cohort
study. Clin Sci (Lond). 1998;94:405–412. [PubMed: 9640346]

209.

Polatti F, Capuzzo E, Viazzo F, Colleoni R, Klersy C. Bone mineral changes during and after lactation. Obstet Gynecol. 1999;94:52–56.
[PubMed: 10389717]

210.

Kalkwarf HJ, Specker BL, Bianchi DC, Ranz J, Ho M. The effect of calcium supplementation on bone density during lactation and after weaning. N Engl J Med. 1997;337:523–528.
[PubMed: 9262495]

211.

Cross NA, Hillman LS, Allen SH, Krause GF. Changes in bone mineral density and markers of bone remodeling during lactation and postweaning in women consuming high amounts of calcium. J Bone Miner Res. 1995;10:1312–1320.
[PubMed: 7502702]

212.

Laskey MA, Prentice A, Hanratty LA, Jarjou LM, Dibba B, Beavan SR, Cole TJ. Bone changes after 3 mo of lactation: influence of calcium intake, breast-milk output, and vitamin D-receptor genotype. Am J Clin Nutr. 1998;67:685–692.
[PubMed: 9537615]

213.

Teti A, Zallone A. Do osteocytes contribute to bone mineral homeostasis? Osteocytic osteolysis revisited. Bone. 2009;44:11–16.
[PubMed: 18977320]

214.

Qing H, Ardeshirpour L, Pajevic PD, Dusevich V, Jahn K, Kato S, Wysolmerski J, Bonewald LF. Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation. J Bone Miner Res. 2012;27:1018–1029.
[PMC free article: PMC3770147] [PubMed: 22308018]

215.

Kirby BJ, Ardeshirpour L, Woodrow JP, Wysolmerski JJ, Sims NA, Karaplis AC, Kovacs CS.
Skeletal recovery after weaning does not require PTHrP. J Bone Miner Res. 2011;26:1242–1251. [PMC free article: PMC3179289] [PubMed:
21308774]

216.

Collins JN, Kirby BJ, Woodrow JP, Gagel RF, Rosen CJ, Sims NA, Kovacs CS. Lactating Ctcgrp nulls lose twice the normal bone mineral content due to fewer osteoblasts and more osteoclasts, whereas bone mass is fully restored after weaning in association with up-regulation of Wnt signaling and other novel genes. Endocrinology. 2013;154:1400–1413.
[PMC free article: PMC3678150] [PubMed: 23462960]

217.

Liu XS, Ardeshirpour L, VanHouten JN, Shane E, Wysolmerski JJ. Site-specific changes in
bone microarchitecture, mineralization, and stiffness during lactation and after weaning in mice. J Bone Miner Res. 2012;27:865–875. [PubMed: 22189918]

218.

Bjornerem A, Ghasem-Zadeh A, Wang X, Bui M, Walker SP, Zebaze R, Seeman E. Irreversible Deterioration of Cortical and
Trabecular Microstructure Associated With Breastfeeding. J Bone Miner Res. 2017;32:681–687. [PubMed: 27736021]

219.

Brembeck P, Lorentzon M, Ohlsson C, Winkvist A, Augustin H. Changes in cortical volumetric bone mineral density and thickness, and trabecular thickness in
lactating women postpartum. J Clin Endocrinol Metab. 2015;100:535–543. [PubMed: 25387262]

220.

Wiklund PK, Xu L, Wang Q, Mikkola T, Lyytikainen A, Volgyi E, Munukka E, Cheng SM, Alen M, Keinanen-Kiukaanniemi S, Cheng S. Lactation is associated with greater maternal bone size
and bone strength later in life. Osteoporos Int. 2012;23:1939–1945. [PubMed: 21927916]

221.

Bowman BM, Miller SC. Skeletal adaptations during mammalian reproduction. J Musculoskelet Neuronal Interact. 2001;1:347–355.
[PubMed: 15758485]

222.

Vajda EG, Bowman BM, Miller SC. Cancellous and cortical bone mechanical properties and tissue dynamics during pregnancy, lactation, and postlactation in the rat. Biol Reprod. 2001;65:689–695.
[PubMed: 11514329]

223.

Reid IR, Wattie DJ, Evans MC, Budayr AA. Post-pregnancy osteoporosis associated with hypercalcaemia. Clin Endocrinol (Oxf). 1992;37:298–303.
[PubMed: 1424213]

224.

Ghaznavi SA, Saad NM, Donovan LE. The Biochemical Profile of Familial Hypocalciuric Hypercalcemia and Primary Hyperparathyroidism during Pregnancy and Lactation: Two Case Reports and Review of the Literature. Case reports in endocrinology. 2016;2016:2725486.
[PMC free article: PMC5120212] [PubMed: 27957351]

225.

VanHouten J, Dann P, McGeoch G, Brown EM, Krapcho K, Neville M, Wysolmerski JJ.
The calcium-sensing receptor regulates mammary gland parathyroid hormone-related protein production and calcium transport. J Clin Invest. 2004;113:598–608. [PMC free article: PMC338258] [PubMed: 14966569]

226.

Ardeshirpour L, Dann P, Pollak M, Wysolmerski J, VanHouten J. The calcium-sensing receptor regulates PTHrP production and calcium transport in the lactating mammary gland. Bone. 2006;38:787–793.
[PubMed: 16377269]

227.

Caplan RH, Beguin EA. Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation. Obstet Gynecol. 1990;76:485–489.
[PubMed: 2381632]

228.

Salle BL, Berthezene F, Glorieux FH, Delvin EE, Berland M, David L, Varenne JP, Putet G. Hypoparathyroidism during pregnancy: treatment with calcitriol. J Clin Endocrinol Metab. 1981;52:810–813.
[PubMed: 6894151]

229.

Sadeghi-Nejad A, Wolfsdorf JI, Senior B. Hypoparathyroidism and pregnancy. Treatment with calcitriol. JAMA. 1980;243:254–255.
[PubMed: 7350374]

230.

Shomali ME, Ross DS. Hypercalcemia in a woman with hypoparathyroidism associated with increased parathyroid hormone-related protein during lactation. Endocr Pract. 1999;5:198–200. [PubMed: 15251676]

231.

Mather KJ, Chik CL, Corenblum B. Maintenance of serum calcium by parathyroid hormone-related peptide during lactation in a hypoparathyroid patient. J Clin Endocrinol Metab. 1999;84:424–427.
[PubMed: 10022395]

232.

Rideout KL. When endocrine disorders disrupt pregnancy: perspectives of affected mothers. In: Kovacs CS, Deal CL, eds. Maternal-Fetal and Neonatal Endocrinology: Physiology, Pathophysiology, and Clinical Management. San Diego: Academic Press; 2019:xxxvii-xli.

233.

Wagner
CL, Hulsey TC, Fanning D, Ebeling M, Hollis BW. High-dose vitamin D3 supplementation in a cohort of breastfeeding mothers and their infants: a 6-month follow-up pilot study. Breastfeed Med. 2006;1:59–70. [PubMed: 17661565]

234.

Prentice A, Jarjou LM, Cole TJ, Stirling DM,
Dibba B, Fairweather-Tait S. Calcium requirements of lactating Gambian mothers: effects of a calcium supplement on breast-milk calcium concentration, maternal bone mineral content, and urinary calcium excretion. Am J Clin Nutr. 1995;62:58–67. [PubMed: 7598067]

235.

Prentice
A, Jarjou LM, Stirling DM, Buffenstein R, Fairweather-Tait S. Biochemical markers of calcium and bone metabolism during 18 months of lactation in Gambian women accustomed to a low calcium intake and in those consuming a calcium supplement. J Clin Endocrinol Metab. 1998;83:1059–1066. [PubMed:
9543117]

236.

Prentice A, Yan L, Jarjou LM, Dibba B, Laskey MA, Stirling DM, Fairweather-Tait S. Vitamin D status does not influence the breast-milk calcium concentration of lactating mothers accustomed to a low calcium intake. Acta Paediatr. 1997;86:1006–1008. [PubMed:
9343285]

237.

Bezerra FF, Mendonca LM, Lobato EC, O’Brien KO, Donangelo CM. Bone mass is recovered from lactation to postweaning in adolescent mothers with low calcium intakes. Am J Clin Nutr. 2004;80:1322–1326. [PubMed: 15531682]

238.

Chantry
CJ, Auinger P, Byrd RS. Lactation among adolescent mothers and subsequent bone mineral density. Arch Pediatr Adolesc Med. 2004;158:650–656. [PubMed: 15237064]

239.

Delzer PR, Meyer RA Jr. Normal milk composition in lactating X-linked hypophosphatemic mice despite continued
hypophosphatemia. Calcif Tissue Int. 1983;35:750–754. [PubMed: 6689137]

Which of the following include nutrients that are most commonly deficient during pregnancy?

Which of the following is among the minerals that are in great demand during pregnancy because they are involved in building the skeleton?

Why is there a need for increased protein intake during pregnancy quizlet?

Can you breastfeed pregnant?

Bạn đang tìm hiểu bài viết:  Which of the following statements is false regarding calcium needs during pregnancy? 2024

HỆ THỐNG CỬA HÀNG TRÙM SỈ QUẢNG CHÂU

Điện thoại: 092.484.9483

Zalo: 092.484.9483

Facebook: https://facebook.com/giatlathuhuongcom/

Website: Trumsiquangchau.com

Địa chỉ: Ngõ 346 Nam Dư, Trần Phú, Hoàng Mai, Hà Nội.